-
Je něco špatně v tomto záznamu ?
Reactivation of VX-Inhibited Human Acetylcholinesterase by Deprotonated Pralidoxime. A Complementary Quantum Mechanical Study
JAV. da Silva, AF. Pereira, SR. LaPlante, K. Kuca, TC. Ramalho, TCC. França
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
308225/2018-0
CAPES, CNPq - International
E-02/202.961/2017
FAPEMIG and FAPERJ - International
NLK
Directory of Open Access Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
PubMed
32012780
DOI
10.3390/biom10020192
Knihovny.cz E-zdroje
- MeSH
- acetylcholinesterasa chemie účinky léků MeSH
- katalytická doména MeSH
- kvantová teorie MeSH
- lidé MeSH
- molekulární konformace MeSH
- organothiofosforové sloučeniny farmakologie MeSH
- pralidoximové sloučeniny chemie farmakologie MeSH
- protony MeSH
- serin chemie MeSH
- simulace molekulární dynamiky MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
In the present work, we performed a complementary quantum mechanical (QM) study to describe the mechanism by which deprotonated pralidoxime (2-PAM) could reactivate human (Homo sapiens sapiens) acetylcholinesterase (HssAChE) inhibited by the nerve agent VX. Such a reaction is proposed to occur in subsequent addition-elimination steps, starting with a nucleophile bimolecular substitution (SN2) mechanism through the formation of a trigonal bipyramidal transition state (TS). A near attack conformation (NAC), obtained in a former study using molecular mechanics (MM) calculations, was taken as a starting point for this project, where we described the possible formation of the TS. Together, this combined QM/MM study on AChE reactivation shows the feasibility of the reactivation occurring via attack of the deprotonated form of 2-PAM against the Ser203-VX adduct of HssAChE.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21012909
- 003
- CZ-PrNML
- 005
- 20210716112009.0
- 007
- ta
- 008
- 210420s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/biom10020192 $2 doi
- 035 __
- $a (PubMed)32012780
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a da Silva, Jorge Alberto Valle $u Chemical, Biological, Radiological and Nuclear Defense Institute, Avenida das Americas, 28705, Guaratiba, 23020-470 Rio de Janeiro/RJ, Brazil
- 245 10
- $a Reactivation of VX-Inhibited Human Acetylcholinesterase by Deprotonated Pralidoxime. A Complementary Quantum Mechanical Study / $c JAV. da Silva, AF. Pereira, SR. LaPlante, K. Kuca, TC. Ramalho, TCC. França
- 520 9_
- $a In the present work, we performed a complementary quantum mechanical (QM) study to describe the mechanism by which deprotonated pralidoxime (2-PAM) could reactivate human (Homo sapiens sapiens) acetylcholinesterase (HssAChE) inhibited by the nerve agent VX. Such a reaction is proposed to occur in subsequent addition-elimination steps, starting with a nucleophile bimolecular substitution (SN2) mechanism through the formation of a trigonal bipyramidal transition state (TS). A near attack conformation (NAC), obtained in a former study using molecular mechanics (MM) calculations, was taken as a starting point for this project, where we described the possible formation of the TS. Together, this combined QM/MM study on AChE reactivation shows the feasibility of the reactivation occurring via attack of the deprotonated form of 2-PAM against the Ser203-VX adduct of HssAChE.
- 650 _2
- $a acetylcholinesterasa $x chemie $x účinky léků $7 D000110
- 650 _2
- $a katalytická doména $7 D020134
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární konformace $7 D008968
- 650 _2
- $a simulace molekulární dynamiky $7 D056004
- 650 _2
- $a organothiofosforové sloučeniny $x farmakologie $7 D009946
- 650 _2
- $a pralidoximové sloučeniny $x chemie $x farmakologie $7 D011220
- 650 _2
- $a protony $7 D011522
- 650 _2
- $a kvantová teorie $7 D011789
- 650 _2
- $a serin $x chemie $7 D012694
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pereira, Ander Francisco $u Laboratory of Molecular Modeling, Chemistry Department, Federal University of Lavras, 37200-000 Lavras, MG, Brazil
- 700 1_
- $a LaPlante, Steven R $u INRS-Centre Armand-Frapier Santé Biotechnologie, 531 boulevard des Prairies, Laval, QC H7V 1B7, Canada
- 700 1_
- $a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003 Hradec Kralove, Czech Republic
- 700 1_
- $a Ramalho, Teodorico Castro $u Laboratory of Molecular Modeling, Chemistry Department, Federal University of Lavras, 37200-000 Lavras, MG, Brazil ; Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense (LMCBD), Military Institute of Engineering, Praça General Tiburcio 80, Urca, 22290-270 Rio de Janeiro/RJ, Brazil
- 700 1_
- $a França, Tanos Celmar Costa $u INRS-Centre Armand-Frapier Santé Biotechnologie, 531 boulevard des Prairies, Laval, QC H7V 1B7, Canada ; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 50003 Hradec Kralove, Czech Republic ; Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense (LMCBD), Military Institute of Engineering, Praça General Tiburcio 80, Urca, 22290-270 Rio de Janeiro/RJ, Brazil
- 773 0_
- $w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 10, č. 2 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32012780 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210716112009 $b ABA008
- 999 __
- $a ok $b bmc $g 1651145 $s 1133288
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 10 $c 2 $e 20200127 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
- GRA __
- $a 308225/2018-0 $p CAPES, CNPq $2 International
- GRA __
- $a E-02/202.961/2017 $p FAPEMIG and FAPERJ $2 International
- LZP __
- $a Pubmed-20210420